Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

The combination of Arginine Silicate Inositol Complex and a new form of Biotin improved hair and nail growth in rats.

PRP treatment helps hair growth and rebalances scalp bacteria in androgenetic alopecia patients.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Six months after COVID-19, most patients still had autoantibodies.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Female pattern hair loss does not significantly affect sexual dysfunction.

Alopecia significantly harms emotional and social well-being.

μ-opiate receptors in skin cells may affect skin health and healing.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

There is a significant need for better-validated quality of life tools in dermatology.

Laminin 332 is essential for normal skin cell behavior and structure.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

New skin imaging, teledermatology, and AI could become key in future dermatology care.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.